Gensight Biologics S.A.
Gene therapy to treat inherited diseases of the eye and central nervous system
🤖
AI Overview
With $70K in lobbying spend across 3 quarterly filings, Gensight Biologics S.A is an active lobbying client. Their lobbying covers 2 issue areas.
$70K
Total Spend
1
Years Active
1
Firms Hired
3
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2023 | $70K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Pharmacy
- •Rare disease drug development Orphan Drug Act Orphan Drug Tax Credit Priority Review Voucher Expedited approval pathways Patient-focused drug development
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
America's Health Insurance Plans INC (Ahip)
$96.4M total spend
Health Care Service Corporation, a Mutual Legal Reserve Company (Hcsc)
$52.8M total spend
Walgreen Company
$24.4M total spend
Mckesson Corporation & Affiliates U.S. Oncology and Rx Savings Solutions
$22.7M total spend
Advocate Aurora Health, INC.
$16.8M total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.